Multi-omic Profiling Reveals Early Immunological Indicators for Identifying COVID-19 Progressors

Katherine A Drake1, Dimitri Talantov2, Gary J Tong1

  • 1Verily Life Sciences, South San Francisco, CA.

Summary

Early immune changes in COVID-19 patients predict disease severity. Scientists identified distinct blood cell and cytokine profiles in individuals progressing to severe disease, offering potential prognostic biomarkers.